BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21872636)

  • 1. Protection against the toxic effects of Loxosceles intermedia spider venom elicited by mimotope peptides.
    de Moura J; Felicori L; Moreau V; Guimarães G; Dias-Lopes C; Molina L; Alvarenga LM; Fernandes P; Frézard F; Ribeiro RR; Fleury C; Nguyen C; Molina F; Granier C; Chávez-Olórtegui C
    Vaccine; 2011 Oct; 29(45):7992-8001. PubMed ID: 21872636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vivo protective response against toxic effects of the dermonecrotic protein from Loxosceles intermedia spider venom elicited by synthetic epitopes.
    Felicori L; Fernandes PB; Giusta MS; Duarte CG; Kalapothakis E; Nguyen C; Molina F; Granier C; Chávez-Olórtegui C
    Vaccine; 2009 Jun; 27(31):4201-8. PubMed ID: 19389441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characterization and epitope analysis of a recombinant dermonecrotic protein from Loxosceles intermedia spider.
    Felicori L; Araujo SC; de Avila RA; Sanchez EF; Granier C; Kalapothakis E; Chávez-Olórtegui C
    Toxicon; 2006 Oct; 48(5):509-19. PubMed ID: 16934304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A protective immune response against lethal, dermonecrotic and hemorrhagic effects of Loxosceles intermedia venom elicited by a 27-residue peptide.
    Dias-Lopes C; Guimarães G; Felicori L; Fernandes P; Emery L; Kalapothakis E; Nguyen C; Molina F; Granier C; Chávez-Olórtegui C
    Toxicon; 2010; 55(2-3):481-7. PubMed ID: 19818803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic peptides for in vitro evaluation of the neutralizing potency of Loxosceles antivenoms.
    Ramada JS; Becker-Finco A; Minozzo JC; Felicori LF; Machado de Avila RA; Molina F; Nguyen C; de Moura J; Chávez-Olórtegui C; Alvarenga LM
    Toxicon; 2013 Oct; 73():47-55. PubMed ID: 23856101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective antibodies against a sphingomyelinase D from Loxosceles intermedia spider venom elicited in mice with different genetic background.
    Oliveira CF; Vilela A; Coura LA; Rodrigues FT; Nagem RA; Chávez-Olortegui C; Maioli TU; Felicori LF
    Vaccine; 2016 Jul; 34(33):3828-34. PubMed ID: 27265457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the venom from the Brazilian Brown Spider Loxosceles similis Moenkhaus, 1898 (Araneae, Sicariidae).
    Silvestre FG; de Castro CS; de Moura JF; Giusta MS; De Maria M; Alvares ES; Lobato FC; Assis RA; Gonçalves LA; Gubert IC; Chávez-Olórtegui C; Kalapothakis E
    Toxicon; 2005 Dec; 46(8):927-36. PubMed ID: 16289643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralization of dermonecrotic and lethal activities and differences among 32-35 kDa toxins of medically important Loxosceles spider venoms in Brazil revealed by monoclonal antibodies.
    Guilherme P; Fernandes I; Barbaro KC
    Toxicon; 2001 Sep; 39(9):1333-42. PubMed ID: 11384721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and molecular characterization of a monoclonal antibody reactive with conserved epitope in sphingomyelinases D from Loxosceles spider venoms.
    Dias-Lopes C; Felicori L; Rubrecht L; Cobo S; Molina L; Nguyen C; Galéa P; Granier C; Molina F; Chávez-Olortegui C
    Vaccine; 2014 Apr; 32(18):2086-92. PubMed ID: 24565754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of monoclonal antibodies capable of neutralizing dermonecrotic activity of Loxosceles intermedia spider venom and their use in a specific immunometric assay.
    Alvarenga LM; Martins MS; Moura JF; Kalapothakis E; Oliveira JC; Mangili OC; Granier C; Chávez-Olórtegui C
    Toxicon; 2003 Dec; 42(7):725-31. PubMed ID: 14757202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning and functional characterization of two isoforms of dermonecrotic toxin from Loxosceles intermedia (brown spider) venom gland.
    da Silveira RB; Pigozzo RB; Chaim OM; Appel MH; Dreyfuss JL; Toma L; Mangili OC; Gremski W; Dietrich CP; Nader HB; Veiga SS
    Biochimie; 2006 Sep; 88(9):1241-53. PubMed ID: 16581177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cloning, expression and immunological properties of LiD1, a protein from the dermonecrotic family of Loxosceles intermedia spider venom.
    Kalapothakis E; Araujo SC; de Castro CS; Mendes TM; Gomez MV; Mangili OC; Gubert IC; Chávez-Olórtegui C
    Toxicon; 2002 Dec; 40(12):1691-9. PubMed ID: 12457881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against dermonecrotic and lethal activities of Loxosceles intermedia spider venom by immunization with a fused recombinant protein.
    Araujo SC; Castanheira P; Alvarenga LM; Mangili OC; Kalapothakis E; Chávez-Olórtegui C
    Toxicon; 2003 Mar; 41(3):261-7. PubMed ID: 12565747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic characterization, antigenic cross-reactivity and neutralization of dermonecrotic activity of five Loxosceles spider venoms of medical importance in the Americas.
    Barbaro KC; Knysak I; Martins R; Hogan C; Winkel K
    Toxicon; 2005 Mar; 45(4):489-99. PubMed ID: 15733571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of antibody-reactive peptides from discontinuous parts of scorpion toxins.
    Alvarenga L; Moreau V; Felicori L; Nguyen C; Duarte C; Chavez-Olortegui C; Molina F; Martin-Eauclaire MF; Granier C
    Vaccine; 2010 Jan; 28(4):970-80. PubMed ID: 19962461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and characterization of a recombinant chimeric protein (rCpLi) consisting of B-cell epitopes of a dermonecrotic protein from Loxosceles intermedia spider venom.
    Mendes TM; Oliveira D; Figueiredo LF; Machado-de-Avila RA; Duarte CG; Dias-Lopes C; Guimarães G; Felicori L; Minozzo JC; Chávez-Olortegui C
    Vaccine; 2013 Jun; 31(25):2749-55. PubMed ID: 23664158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous loxoscelism caused by Loxosceles similis venom and neutralization capacity of its specific antivenom.
    Chatzaki M; Horta CC; Almeida MO; Pereira NB; Mendes TM; Dias-Lopes C; Guimarães G; Moro L; Chávez-Olórtegui C; Horta MC; Kalapothakis E
    Toxicon; 2012 Jul; 60(1):21-30. PubMed ID: 22465492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant Protein Containing B-Cell Epitopes of Different
    Lima SA; Guerra-Duarte C; Costal-Oliveira F; Mendes TM; Figueiredo LFM; Oliveira D; Machado de Avila RA; Ferrer VP; Trevisan-Silva D; Veiga SS; Minozzo JC; Kalapothakis E; Chávez-Olórtegui C
    Front Immunol; 2018; 9():653. PubMed ID: 29666624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo protection against Tityus serrulatus scorpion venom by antibodies raised against a discontinuous synthetic epitope.
    Duarte CG; Alvarenga LM; Dias-Lopes C; Machado-de-Avila RA; Nguyen C; Molina F; Granier C; Chávez-Olórtegui C
    Vaccine; 2010 Feb; 28(5):1168-76. PubMed ID: 19948263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astacin-like metalloproteases are a gene family of toxins present in the venom of different species of the brown spider (genus Loxosceles).
    Trevisan-Silva D; Gremski LH; Chaim OM; da Silveira RB; Meissner GO; Mangili OC; Barbaro KC; Gremski W; Veiga SS; Senff-Ribeiro A
    Biochimie; 2010 Jan; 92(1):21-32. PubMed ID: 19879318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.